Form 4: Maravai LifeSciences Holdings General Counsel Kurt Oreshack Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Kurt Oreshack, General Counsel of Maravai LifeSciences Holdings, reports the disposal of 2,028 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Kurt Oreshack, General Counsel of Maravai LifeSciences Holdings, reported a transaction involving Class A Common Stock.
- The transaction involved the disposal of 2,028 shares to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $4.1.
- Following the transaction, Oreshack directly owns 165,590 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a standard tax-related stock disposal, which is common when restricted stock units vest.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: disposal of shares to cover tax obligations. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.